ICD-10 Coding for Urothelial Carcinoma of the Bladder(C67.0, C67.0B, C67.0M)
Learn about ICD-10 coding for urothelial carcinoma of the bladder, including subsite-specific codes and documentation requirements.
Complete code families applicable to Urothelial Carcinoma of the Bladder
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C67.0 | Malignant neoplasm of trigone of bladder | Use when the tumor is specifically located at the trigone of the bladder. |
|
| C67.9 | Malignant neoplasm of bladder, unspecified | Use when the specific subsite of the bladder is not documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutUrothelial Carcinoma of the Bladder
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Urothelial Carcinoma of the Bladder.
Omitting subsite information
Impact
Clinical: May affect treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential for incorrect billing and reimbursement.
Mitigation
Ensure detailed operative notes, Cross-check pathology reports
Using C67.9 for single tumors with known subsites
Impact
Reimbursement: May lead to incorrect DRG assignment., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases specificity and accuracy of clinical data.
Mitigation
Ensure documentation specifies the exact subsite of the tumor.
Subsite specificity
Impact
Failure to document specific subsite can lead to audit issues.
Mitigation
Implement thorough documentation protocols.